Molecular Profiling of Pancreatic Cancer Patients-Letter.

We read with great interest the article by Pishvaian and colleagues ([1][1]) that explored the clinical implications of molecular profiling of pancreatic adenocarcinoma and reported various actionable genes that may provide guidance for clinicians to practice precision medicine. The authors reported